References
- Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.), 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
- Anuj, K., Gaurav, C., Sanjeev, K. S., Mansi, S., Pankaj, T., Arvind, V., & Madhu, S. (2020). Identification of phytochemical inhibitors againstmain protease of COVID-19 using molecularmodeling approaches. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1772112.
- Beadling, C., & Slifka, M. K. (2004). How do viral infections predispose patients to bacterial infections? Current Opinion in Infectious Diseases, 17(3), 185–191. https://doi.org/https://doi.org/10.1097/00001432-200406000-00003
- Becke, A. (1997). A new inhomogeneity parameter in density-functional theory. Journal of Chemical Physics, 107(20), 8554–8560. https://doi.org/https://doi.org/10.1063/1.475007
- Benson, N. C., & Daggett, V. (2012). A comparison of multiscale methods for the analysis of molecular dynamics simulations. The Journal of Physical Chemistry. B, 116(29), 8722–8731. https://doi.org/https://doi.org/10.1021/jp302103t 22494262
- Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: A messagepassing parallel molecular dynamics implementation. Computer Physics Communications, 91(1–3), 43–56. https://doi.org/https://doi.org/10.1016/0010-4655(95)00042-E
- Bhardwaj, V. J., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1766572.
- Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1758788.
- Chang, C., Lo, S.-C., Wang, Y.-S., & Hou, M.-H. (2016). Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein. Drug Discovery Today, 21(4), 562–572. https://doi.org/https://doi.org/10.1016/j.drudis.2015.11.015
- Cheng, F., Li, W., Wang, X., Zhou, Y., Wu, Z., Shen, J., & Tang, Y. (2013). Adverse drug events: Database construction and in silico prediction. Journal of Chemical Information and Modeling, 53(4), 744–752. https://doi.org/https://doi.org/10.1021/ci4000079
- Corbin, K. D., & Zeisel, S. H. (2012). Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Current Opinion in Gastroenterology, 28(2), 159–165. https://doi.org/https://doi.org/10.1097/MOG.0b013e32834e7b4b
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/https://doi.org/10.1038/srep42717
- Dassault Systèmes BIOVIA. (2017). Discovery studio modeling environment, Release. Dassault Systèmes.
- Dayer, M. R., Taleb-Gassabi, S., & Dayer, M. S. (2017). A potent drug against coronavirus infection: Insight from molecular docking study. Archives of Clinical Infectious Diseases, 12(4), e13823. https://doi.org/https://doi.org/10.5812/archcid.13823
- de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016). SARS and MERS: Recent insights into emerging coronaviruses. Nature Reviews. Microbiology, 14(8), 523–534. https://doi.org/https://doi.org/10.1038/nrmicro.2016.81
- Dewick, P. (2009). Medicinal natural products: A biosynthetic approach (3rd ed., p. 357). Wiley. ISBN 978-0-471-49641-0.
- Doremalen, N., Morris, D., & Bushmaker, T. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine. https://doi.org/https://doi.org/10.1056/NEJMc2004973.
- Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2020). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in-silico approach. Journal of Biomolecular Structure and Dynamics.
- Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. Methods in Molecular Biology (Clifton, N.J.), 1282, 1–23. https://doi.org/https://doi.org/10.1007/978-1-4939-2438-7_1
- Frisch, M. J. (2004). Gaussian 09, revision D.01. Gaussian Inc.
- Gajula, M. N. P., Kumar, A., & Ijaq, J. (2016). Protocol for molecular dynamics simulations of proteins. Bio-Protocol, 6(23), 1–11. https://doi.org/https://doi.org/10.21769/BioProtoc.2051
- Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H., Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., … Rao, Z. (2020). Structure of the RNA dependent RNA polymerase from COVID-19 virus. Science, 368(6492), 779–779. https://doi.org/https://doi.org/10.1126/science.abb7498
- Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K. M., Hoffmaster, K. A., Ishikawa, T., Keppler, D., Kim, R. B., Lee, C. A., Niemi, M., Polli, J. W., Sugiyama, Y., Swaan, P. W., … Zhang, L. (2010). Membrane transporters in drug development. Nature Reviews. Drug Discovery, 9(3), 215–236. https://doi.org/https://doi.org/10.1038/nrd3028
- Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., Penzar, D., Perlman, S., Poon, L. L. M., Samborskiy, D. V., Sidorov, I. A., Sola, I., & Ziebuhr, J. (2020). The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology. https://doi.org/https://doi.org/10.1038/s41564-020-0695-z.
- Gorden, D. E., Gwendolyn, M. J., & Bouhaddou, M. (2020). A SARS-CoV-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing. bioRxiv. https://doi.org/https://doi.org/10.1101/2020.03.22.002386.
- Graham, R. L., Donaldson, E. F., & Baric, R. S. (2013). A decade after SARS: Strategies for controlling emerging coronaviruses. Nature Reviews Microbiology, 11(12), 836–848. https://doi.org/https://doi.org/10.1038/nrmicro3143
- Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., Nicastri, E., Oda, R., Yo, K., Quiros-Roldan, E., Studemeister, A., Redinski, J., Ahmed, S., Bernett, J., Chelliah, D., … Flanigan, T. (2020). Compassionate use of remdesivir for patients with severe Covid-19. The New England Journal of Medicine, 382(24), 2327–2336. https://doi.org/https://doi.org/10.1056/NEJMoa2007016
- Guan, W-j., Ni, Z-y., Hu, Y., Liang, W-h., Ou, C-q., He, J-x., Liu, L., Shan, H., Lei, C-l., Hui, D. S. C., Du, B., Li, L-j., Zeng, G., Yuen, K.-Y., Chen, R-c., Tang, C-l., Wang, T., Chen, P-y., Xiang, J., … Zhong, N-s. (2020). Clinical characteristics of Coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/https://doi.org/10.1056/NEJMoa2002032
- Guo, Y., Cao, Q., Hong, Z., Tan, Y., Chen, S., Jin, H., Tan, K., Wang, D., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Military Medical Research, 7(1), 11. https://doi.org/https://doi.org/10.1186/s40779-020-00240-0
- Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severeacute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/https://doi.org/10.1080/07391102.2020.1751300.
- Hendaus, M. A. (2020). Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1767691.
- Hendaus, M. A., & Jomha, F. A. (2020). Covid-19 induced superimposed bacterial infection. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1772110.
- Jee, B., Kumar, S., Yadav, R., Singh, Y., Kumar, A., & Sharma, M. (2018). Ursolic acid and carvacrol may be potential inhibitors of dormancy protein small heat shock protein16.3 of Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics, 36(13), 3434–3443. https://doi.org/https://doi.org/10.1080/07391102.2017.1389305
- Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C. W., & Xia, Z. (2020). Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). Journal of General Internal Medicine, 35(5), 1545–1549. https://doi.org/https://doi.org/10.1007/s11606-020-05762-w
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Kaisari, E., & Borruat, F. (2020). Keeping an eye on hydroxychloroquine retinopathy. KlinischeMonatsblätterfürAugenheilkunde.
- Khaerunnisa, S., Kurniawan, H., Awaluddin, R., Suhartati, S., & Soetjipto, S. (2020). Potential inhibitor of COVID–19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints, 1–14.
- Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-Cov-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1751298.
- Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, E., Pathak, A., Singh, R. P., Muthukumaran, J., Singh, A. K. (2020). Targeting SARS-CoV-2; a systematic drug repurposing approach to identify promising inhibitors against 3c-like proteinase and 2’-o-ribose methyltransferase. Journal of Biomoleular Structure and Dynamics, 1–14. https://doi.org/10.101080/07391102.2020.1753577.
- Kumar, A., Kumar, R., Sharma, M., Kumar, U., Gajula, M. N. P., & Singh, K. P. (2018). Uttarakhand medicinal plants database (UMPDB): A platform for exploring genomic, chemical, and traditional knowledge. Data (Data), 3(1), 7. https://doi.org/https://doi.org/10.3390/data3010007
- Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today. Technologies, 1(4), 337–341. https://doi.org/https://doi.org/10.1016/j.ddtec.2004.11.007
- Mayo, S. L., Olafson, B. D., & Goddard, W. A. (1990). A generic force field for molecular simulations. The Journal of Physical Chemistry, 94(26), 8897–8909. https://doi.org/https://doi.org/10.1021/j100389a010
- Mesecar, A. D. (2020). A taxonomically-driven approach to development of potent, broad-spectrum inhibitors of coronavirus main protease including SARS-CoV-2 (COVID-19). https://www.rcsb.org/structure/6W63. https://doi.org/https://doi.org/10.2210/pdb6W63/pdb
- Michel, F. S. (1999). Python: A programming language for software integration and development. Journal of Molecular Graphics & Modelling, 17, 57–61.
- Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A., & Varma, A. K. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PLoS One, 5(8), e12029. https://doi.org/https://doi.org/10.1371/journal.pone.0012029
- Rameez, J. K., Rajat, K. J., Gizachew, M. A., Monika, J., Ekampreet, S., Amita, P., Rashmi, P. S., Jayaraman, M., & Amit, K. S. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-Oribose methyltransferase. Journal of Biomolecular Structure and Dynamics. https://doi.org/https://doi.org/10.1080/07391102.2020.1753577.
- Rana, M., & Chowdhury, P. (2017). Perturbation of hydrogen bonding in hydrated pyrrole-2-carboxaldehyde complexes. Journal of Molecular Modelling, 23, 216.
- Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., Seilmaier, M., Drosten, C., Vollmar, P., Zwirglmaier, K., Zange, S., W€Olfel, R., & Hoelscher, M. (2020). Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine, 382(10), 970–971. https://doi.org/https://doi.org/10.1056/NEJMc2001468
- Rudkowska, I., AbuMweis, S. S., Nicolle, C., & Jones, P. J. (2008). Cholesterol-lowering efficacy of plant sterols in low-fat yogurt consumed as a snack or with a meal. Journal of the American College of Nutrition, 27(5), 588–595. https://doi.org/https://doi.org/10.1080/07315724.2008.10719742
- Salata, C., Calistri, A., Parolin, C., & Palù, G. (2019). Coronaviruses: A paradigm of new emerging zoonotic diseases. Pathogens and Disease, 77(9), ftaa006. https://doi.org/https://doi.org/10.1093/femspd/ftaa006
- Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019- nCoV N-protein (N terminal domain). Journal of Biomolecular Structure, & Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1753580.
- Sharma, P., Dwivedee, B. P., Bisht, D., Dash, A. K., & Kumar, D. (2019). The chemical constituents and diverse pharmacological importance of Tinospora cordifolia. Heliyon, 5(9), e02437. https://doi.org/https://doi.org/10.1016/j.heliyon.2019.e02437
- Singla, N., & Chowdhury, P. (2014). Inclusion behaviour of Indole-7-Carboxaldehyde inside β-cyclodextrin: A nano cage. Chemical Physics, 441, 93–100. https://doi.org/https://doi.org/10.1016/j.chemphys.2014.07.009
- Sonkamble, V. V., & Kamble, L. H. (2015). Antidiabetic potential and identification of phytochemicals from Tinospora cordifolia. American Journal of Phytomedicine and Clinical Therapeutics, 3(2015), 97–110.
- Soteras, I. S., Lin, F.-Y., Vanommeslaeghe, K., Lemkul, J. A., Armacost, K. A., Brooks, C., III,., & MacKerell, A. D. Jr., (2016). Parametrization of halogen bonds in the CHARMM General Force Field: Improved treatment of ligand-protein interactions. Bioorganic & Medicinal Chemistry. https://doi.org/https://doi.org/10.1016/j.bmc.2016.06.034.
- Taylor, J. C., Rapport, L., & Lockwood, G. B. (2003) Octacosanol in human health. Nutrition, 19(2), 192–195. https://doi.org/https://doi.org/10.1016/S0899-9007(02)00869-9
- Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/https://doi.org/10.1002/jcc.21334
- van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J., Wolthers, K. C., Wertheim-van Dillen, P. M., Kaandorp, J., Spaargaren, J., & Berkhout, B. (2004). Identification of a new human coronavirus. Nature Medicine, 10(4), 368–373. https://doi.org/https://doi.org/10.1038/nm1024
- Vanommeslaeghe, K., & MacKerell, A. D. (2012). Automation of the CHARMM General Force Field (CGenFF) I: Bond perception and atom typing. Journal of Chemical Information and Modeling, 52(12), 3144–3154. PMC3528824. https://doi.org/https://doi.org/10.1021/ci300363c
- Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/https://doi.org/10.1021/jm020017n
- Velavan, T. P., & Meyer, C. G. (2020). The COVID-19 epidemic. Tropical Medicine & International Health: TM & IH, 25(3), 278–280. https://doi.org/https://doi.org/10.1111/tmi.13383
- Wang, B., Guo, H., Ling, L., Ji, J., Niu, J., & Gu, Y. (2020). The chronic adverse effect of chloroquine on kidney in rats through an autophagy dependent and independent pathways. Nephron, 144(2), 96–64. https://doi.org/https://doi.org/10.1159/000503882
- Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 323(11), 1061. https://doi.org/https://doi.org/10.1001/jama.2020.1585
- Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Research, 30(3), 269–271. https://doi.org/https://doi.org/10.1038/s41422-020-0282-0
- Wang, Z., Guo, X., Liu, Z., Cui, M., Song, F., & Liu, S. (2008). Studies on alkaloids binding to GC-rich human survivin promoter DNA using positive and negative ion electrospray ionization mass spectrometry. Journal of Mass Spectrometry: JMS, 43(3), 327–335. https://doi.org/https://doi.org/10.1002/jms.1320
- Weiss, P., & Murdoch, D. R. (2020). Clinical course and mortality risk of severe COVID-19. The Lancet, 395(10229), 1014–1015. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30633-4
- Woo, P. C. Y., Lau, S. K. P., Chu, C-m., Chan, K-h., Tsoi, H-w., Huang, Y., Wong, B. H. L., Poon, R. W. S., Cai, J. J., Luk, W-k., Poon, L. L. M., Wong, S. S. Y., Guan, Y., Peiris, J. S. M., & Yuen, K.-Y. (2005). Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. Journal of Virology, 79(2), 884–895. https://doi.org/https://doi.org/10.1128/JVI.79.2.884-895.2005
- Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.- W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/https://doi.org/10.1038/s41586-020-2008-3
- Yuriev, E., Agostino, M., & Ramsland, P. A. (2011). Challenges and advances in computational docking: 2009 in review. Journal of Molecular Recognition: JMR, 24(2), 149–164. https://doi.org/https://doi.org/10.1002/jmr.1077
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-Cov-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405